TGFB1 and pulmonary fibrosis: When the secretion of pro-fibrotic cytokines CD206, CD163, TGF-β, IL-10, and IL-12 are blocked, the conversion of fibroblast to myofibroblast is reduced, thus alleviating the progression of BLM-induced pulmonary fibrosis (Liu et al., 2022).